Registration is now open for the FierceBiotech Executive Breakfast & Panel Discussions during the J.P Morgan Healthcare Conference on January 14th. This year's event will feature a full breakfast, two panel discussions, networking, and an ask the experts closing reception.

Seats are limited and last year featured a sold out event! Click here to register today.

This panel will discuss the challenges to commercializing cell-based and gene therapies, and explore how drugmakers are leveraging emerging technologies to meet production requirements, maximize efficiency, and track patients’ progress for performance-based payment deals.

Speakers include:
• Marc Funk / Chief Executive Officer / Lonza Group Ltd.
• David J. Lennon, Ph.D. / President / AveXis, a Novartis Company
• Opening Remarks: Keiko Oishi / President and COO / CMIC
• Closing Remarks: Stephen J. Ubl / President and Chief Executive Officer / PhRMA
• Additional speakers to be announced

This panel will discuss how drug discovery is one area where AI systems can revolutionize the process of R&D. And by applying these tools to patient data, from genomics to electronic health records, researchers can gain deeper insights into the populations they’re ultimately trying to treat.

Speakers include:
• Chris Gibson / Co-Founder and CEO / Recursion Pharmaceuticals
• Kevin Julian / Senior Managing Director, Life Sciences / Accenture
• Daphne Koller / CEO and Founder / Insitro
• Christopher McKenna / Global Head of Professional Services & Consulting / Clarivate Analytics
• Alex Zhavoronkov, PhD / Founder and CEO / Insilico Medicine
• Additional speakers to be announced